Inflammatory bowel diseases, ISSN 1078-0998, 1995
Journal
Gastroenterological Endoscopy, ISSN 0387-1207, 12/2018, Volume 60, Issue 12, pp. 2505 - 2511
Journal Article
Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 108 - 119
ObjectivePatients with IBD display substantial heterogeneity in clinical characteristics. We hypothesise that individual differences in the complex interaction...
BACTERIA | CROHNS-DISEASE | VARIANTS | RARE | GENOTYPE | ULCERATIVE-COLITIS | RISK | LOCI | ASSOCIATION | BACTERIAL INTERACTIONS | INFLAMMATORY BOWEL DISEASE | GENETICS | INTESTINAL BACTERIA | CROHNS | GASTROENTEROLOGY & HEPATOLOGY | Severity of Illness Index | Crohn Disease - genetics | Risk Assessment - methods | Genetic Predisposition to Disease | Humans | Middle Aged | Colitis, Ulcerative - genetics | Male | Colitis, Ulcerative - pathology | Dysbiosis - complications | Dysbiosis - microbiology | Gastrointestinal Microbiome - genetics | Case-Control Studies | Feces - microbiology | Colitis, Ulcerative - microbiology | Dysbiosis - genetics | Host-Pathogen Interactions - genetics | Crohn Disease - pathology | Inflammatory Bowel Diseases - pathology | Inflammatory Bowel Diseases - genetics | Adult | Crohn Disease - microbiology | Female | Inflammatory Bowel Diseases - microbiology | Inflammatory bowel diseases | Care and treatment | Genetic aspects | Research | Microbiota (Symbiotic organisms) | Genetic variation | Phenotypes | Bacterial infections | Breastfeeding & lactation | rRNA 16S | Pathogenesis | Genomes | Inflammation | Crohn's disease | Family medical history | Crohns disease | Inflammatory bowel disease | Genetic variance | Microbiota | Antibiotics | Intestine | Gastroenterology | Peripheral blood | Genetics | Gene loci | Colon | Endoscopy | Acetic acid | NOD2 protein | Gut microbiota | Healthy controls | Host genetics
BACTERIA | CROHNS-DISEASE | VARIANTS | RARE | GENOTYPE | ULCERATIVE-COLITIS | RISK | LOCI | ASSOCIATION | BACTERIAL INTERACTIONS | INFLAMMATORY BOWEL DISEASE | GENETICS | INTESTINAL BACTERIA | CROHNS | GASTROENTEROLOGY & HEPATOLOGY | Severity of Illness Index | Crohn Disease - genetics | Risk Assessment - methods | Genetic Predisposition to Disease | Humans | Middle Aged | Colitis, Ulcerative - genetics | Male | Colitis, Ulcerative - pathology | Dysbiosis - complications | Dysbiosis - microbiology | Gastrointestinal Microbiome - genetics | Case-Control Studies | Feces - microbiology | Colitis, Ulcerative - microbiology | Dysbiosis - genetics | Host-Pathogen Interactions - genetics | Crohn Disease - pathology | Inflammatory Bowel Diseases - pathology | Inflammatory Bowel Diseases - genetics | Adult | Crohn Disease - microbiology | Female | Inflammatory Bowel Diseases - microbiology | Inflammatory bowel diseases | Care and treatment | Genetic aspects | Research | Microbiota (Symbiotic organisms) | Genetic variation | Phenotypes | Bacterial infections | Breastfeeding & lactation | rRNA 16S | Pathogenesis | Genomes | Inflammation | Crohn's disease | Family medical history | Crohns disease | Inflammatory bowel disease | Genetic variance | Microbiota | Antibiotics | Intestine | Gastroenterology | Peripheral blood | Genetics | Gene loci | Colon | Endoscopy | Acetic acid | NOD2 protein | Gut microbiota | Healthy controls | Host genetics
Journal Article
2001, UK key advances in clinical practice series, xi, 144
Book
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9853, pp. 1590 - 1605
Summary Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the gastrointestinal tract with extraintestinal manifestations and...
Internal Medicine | AVIUM SUBSP PARATUBERCULOSIS | BARRIER DYSFUNCTION | MEDICINE, GENERAL & INTERNAL | INFLAMMATORY-BOWEL-DISEASE | RISK-FACTORS | DENDRITIC CELLS | ULCERATIVE-COLITIS | MONOCLONAL-ANTIBODY | SERIOUS INFECTIONS | ENVIRONMENTAL-FACTORS | GENE ATG16L1 | Crohn Disease - epidemiology | Crohn Disease - therapy | Crohn Disease - genetics | Genome-Wide Association Study | Postoperative Care | Humans | Intestinal Fistula - etiology | Crohn Disease - physiopathology | Colonic Diseases - etiology | Drug Therapy, Combination | Metagenome | Crohn Disease - complications | Prevention | Causes of | Complications and side effects | Care and treatment | Crohn's disease | Diagnosis | Inflammatory bowel disease | Thyroid diseases | Genetic research | Air pollution | Genomes | Family medical history | Autophagy | Viral infections
Internal Medicine | AVIUM SUBSP PARATUBERCULOSIS | BARRIER DYSFUNCTION | MEDICINE, GENERAL & INTERNAL | INFLAMMATORY-BOWEL-DISEASE | RISK-FACTORS | DENDRITIC CELLS | ULCERATIVE-COLITIS | MONOCLONAL-ANTIBODY | SERIOUS INFECTIONS | ENVIRONMENTAL-FACTORS | GENE ATG16L1 | Crohn Disease - epidemiology | Crohn Disease - therapy | Crohn Disease - genetics | Genome-Wide Association Study | Postoperative Care | Humans | Intestinal Fistula - etiology | Crohn Disease - physiopathology | Colonic Diseases - etiology | Drug Therapy, Combination | Metagenome | Crohn Disease - complications | Prevention | Causes of | Complications and side effects | Care and treatment | Crohn's disease | Diagnosis | Inflammatory bowel disease | Thyroid diseases | Genetic research | Air pollution | Genomes | Family medical history | Autophagy | Viral infections
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2016, Volume 22, Issue 11, pp. 3117 - 3126
Inflammatory bowel diseases are characterised by inflammation that compromises the integrity of the epithelial barrier. The intestinal epithelium is not only a...
disease | junction;Ulcerative | colitis;Pouchitis;Crohn’s | Claudin;Tight | Pouchitis | Tight junction | Crohn's disease | Claudin | Ulcerative colitis | LACTOBACILLUS-PLANTARUM | DIFFERENTIAL EXPRESSION | SMALL-INTESTINAL PERMEABILITY | ULCERATIVE-COLITIS | ACTIVE CROHNS-DISEASE | PROTEIN CLAUDIN-1 | EPITHELIAL BARRIER FUNCTION | POLYUNSATURATED FATTY-ACIDS | CLAUDIN-2 EXPRESSION | GASTROENTEROLOGY & HEPATOLOGY | UP-REGULATION | Intestinal Mucosa - metabolism | Humans | Colon - drug effects | Crohn Disease - metabolism | Pouchitis - metabolism | Intestinal Mucosa - drug effects | Pouchitis - complications | Crohn Disease - complications | Colorectal Neoplasms - etiology | Claudins - metabolism | Inflammation Mediators - metabolism | Colitis, Ulcerative - drug therapy | Colorectal Neoplasms - metabolism | Tight Junctions - drug effects | Tight Junctions - metabolism | Colitis, Ulcerative - complications | Anti-Inflammatory Agents - pharmacology | Colon - pathology | Colitis, Ulcerative - metabolism | Colitis, Ulcerative - pathology | Pouchitis - drug therapy | Permeability | Colon - metabolism | Animals | Crohn Disease - pathology | Crohn Disease - drug therapy | Pouchitis - pathology | Colorectal Neoplasms - pathology | Tight Junctions - pathology | Intestinal Mucosa - pathology | Review | Crohn’s disease
disease | junction;Ulcerative | colitis;Pouchitis;Crohn’s | Claudin;Tight | Pouchitis | Tight junction | Crohn's disease | Claudin | Ulcerative colitis | LACTOBACILLUS-PLANTARUM | DIFFERENTIAL EXPRESSION | SMALL-INTESTINAL PERMEABILITY | ULCERATIVE-COLITIS | ACTIVE CROHNS-DISEASE | PROTEIN CLAUDIN-1 | EPITHELIAL BARRIER FUNCTION | POLYUNSATURATED FATTY-ACIDS | CLAUDIN-2 EXPRESSION | GASTROENTEROLOGY & HEPATOLOGY | UP-REGULATION | Intestinal Mucosa - metabolism | Humans | Colon - drug effects | Crohn Disease - metabolism | Pouchitis - metabolism | Intestinal Mucosa - drug effects | Pouchitis - complications | Crohn Disease - complications | Colorectal Neoplasms - etiology | Claudins - metabolism | Inflammation Mediators - metabolism | Colitis, Ulcerative - drug therapy | Colorectal Neoplasms - metabolism | Tight Junctions - drug effects | Tight Junctions - metabolism | Colitis, Ulcerative - complications | Anti-Inflammatory Agents - pharmacology | Colon - pathology | Colitis, Ulcerative - metabolism | Colitis, Ulcerative - pathology | Pouchitis - drug therapy | Permeability | Colon - metabolism | Animals | Crohn Disease - pathology | Crohn Disease - drug therapy | Pouchitis - pathology | Colorectal Neoplasms - pathology | Tight Junctions - pathology | Intestinal Mucosa - pathology | Review | Crohn’s disease
Journal Article
1996, Gastroenterology and hepatology, ISBN 0824794109, Volume 1, xiv, 591
Book
Gut, ISSN 0017-5749, 06/2017, Volume 66, Issue 6, pp. 1039 - 1048
ObjectiveThe bacterial intestinal microbiota plays major roles in human physiology and IBDs. Although some data suggest a role of the fungal microbiota in IBD...
INFLAMMATORY BOWEL DISEASE | RESPONSES | SACCHAROMYCES-BOULARDII | INFLAMMATORY-BOWEL-DISEASE | CANDIDA-ALBICANS | MOUSE MODEL | GUT | COLONIZATION | DEFENSINS | GASTROENTEROLOGY & HEPATOLOGY | CHEMICALLY-INDUCED COLITIS | FAMILIAL CROHNS-DISEASE | Crohn Disease - genetics | Ascomycota - isolation & purification | Humans | RNA, Ribosomal, 16S - analysis | Colitis, Ulcerative - genetics | Gastrointestinal Microbiome | Dysbiosis - microbiology | Basidiomycota - isolation & purification | Case-Control Studies | Feces - microbiology | Bacteria - isolation & purification | Colitis, Ulcerative - microbiology | Candida albicans - isolation & purification | Crohn Disease - microbiology | Polymorphism, Single Nucleotide | Saccharomyces cerevisiae - isolation & purification | Host-bacteria relationships | Inflammatory bowel diseases | Research | Microbiota (Symbiotic organisms) | Dysbiosis | Dysbacteriosis | Pathogenesis | Inflammation | Crohn's disease | Biodiversity | Biological diversity | Crohns disease | Inflammatory bowel disease | Fungi | Microbiota | Intestine | Bacteria | Intestinal microflora | Life Sciences | Microbiology and Parasitology | 1506 | Inflammatory Bowel Disease
INFLAMMATORY BOWEL DISEASE | RESPONSES | SACCHAROMYCES-BOULARDII | INFLAMMATORY-BOWEL-DISEASE | CANDIDA-ALBICANS | MOUSE MODEL | GUT | COLONIZATION | DEFENSINS | GASTROENTEROLOGY & HEPATOLOGY | CHEMICALLY-INDUCED COLITIS | FAMILIAL CROHNS-DISEASE | Crohn Disease - genetics | Ascomycota - isolation & purification | Humans | RNA, Ribosomal, 16S - analysis | Colitis, Ulcerative - genetics | Gastrointestinal Microbiome | Dysbiosis - microbiology | Basidiomycota - isolation & purification | Case-Control Studies | Feces - microbiology | Bacteria - isolation & purification | Colitis, Ulcerative - microbiology | Candida albicans - isolation & purification | Crohn Disease - microbiology | Polymorphism, Single Nucleotide | Saccharomyces cerevisiae - isolation & purification | Host-bacteria relationships | Inflammatory bowel diseases | Research | Microbiota (Symbiotic organisms) | Dysbiosis | Dysbacteriosis | Pathogenesis | Inflammation | Crohn's disease | Biodiversity | Biological diversity | Crohns disease | Inflammatory bowel disease | Fungi | Microbiota | Intestine | Bacteria | Intestinal microflora | Life Sciences | Microbiology and Parasitology | 1506 | Inflammatory Bowel Disease
Journal Article
Journal of Crohn's and Colitis, ISSN 1873-9946, 2017, Volume 11, Issue 1, pp. 3 - 25
This paper is the first in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the...
Immunosuppressant | Strictureplasty | Treatment | Perianal disease | Biologics | Thiopurine | Crohn's disease | Vedolizumab | Fistulizing disease | Steroids | perianal disease | treatment | vedolizumab | biologics | thiopurine | steroids | fistulizing disease | strictureplasty | GASTROENTEROLOGY & HEPATOLOGY | Recurrence | Crohn Disease - diagnostic imaging | Intestines - pathology | Humans | Endoscopy, Gastrointestinal | Tomography, X-Ray Computed | Evidence-Based Medicine | Remission Induction | Crohn Disease - therapy | Magnetic Resonance Imaging | Crohn Disease - pathology | Crohn Disease - diagnosis | Intestines - diagnostic imaging
Immunosuppressant | Strictureplasty | Treatment | Perianal disease | Biologics | Thiopurine | Crohn's disease | Vedolizumab | Fistulizing disease | Steroids | perianal disease | treatment | vedolizumab | biologics | thiopurine | steroids | fistulizing disease | strictureplasty | GASTROENTEROLOGY & HEPATOLOGY | Recurrence | Crohn Disease - diagnostic imaging | Intestines - pathology | Humans | Endoscopy, Gastrointestinal | Tomography, X-Ray Computed | Evidence-Based Medicine | Remission Induction | Crohn Disease - therapy | Magnetic Resonance Imaging | Crohn Disease - pathology | Crohn Disease - diagnosis | Intestines - diagnostic imaging
Journal Article
Journal of Crohn's and Colitis, ISSN 1873-9946, 02/2010, Volume 4, Issue 1, pp. 63 - 101
Pregnancy | Psychosomatic | Paediatric | Fistula | Extraintestinal manifestation | Crohn's disease: post-operative recurrence | VITAMIN-D SUPPLEMENTATION | WIRELESS CAPSULE ENDOSCOPY | BONE-MINERAL DENSITY | Crohn's disease | RANDOMIZED CONTROLLED-TRIAL | MULTICENTER PSYCHOTHERAPY TREATMENT | ANTITUMOR NECROSIS FACTOR | post-operative recurrence | INFLAMMATORY-BOWEL-DISEASE | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | QUALITY-OF-LIFE | GASTROENTEROLOGY & HEPATOLOGY | POUCH-ANAL ANASTOMOSIS | Recurrence | Humans | Immunosuppressive Agents - therapeutic use | Arthritis - diagnosis | Intestinal Fistula - etiology | Psychotherapy | Antibodies, Monoclonal - therapeutic use | Male | Adrenal Cortex Hormones - therapeutic use | Crohn Disease - complications | Anti-Bacterial Agents - therapeutic use | Skin Diseases - diagnosis | Infliximab | Crohn Disease - diagnosis | Anti-Inflammatory Agents - therapeutic use | Arthritis - etiology | Female | Purines - therapeutic use | Child | Intestinal Fistula - diagnosis | Crohn Disease - psychology | Intestinal Fistula - therapy | Skin Diseases - drug therapy | Aminosalicylic Acids - therapeutic use | Crohn Disease - therapy | Skin Diseases - etiology | Complementary Therapies | Adolescent | Arthritis - drug therapy | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Pregnancy Complications - therapy | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | MEDICINE | Crohns disease
Journal Article